AngioDynamics to Present at the J.P. Morgan Healthcare Conference
January 06 2020 - 8:00AM
Business Wire
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of
innovative, minimally invasive medical devices for vascular access,
peripheral vascular disease, and oncology, today announced that Jim
Clemmer, President and Chief Executive Officer, and Stephen
Trowbridge, Sr. Vice President, General Counsel, and Interim Chief
Financial Officer, will present at the 38th Annual J.P. Morgan
Healthcare Conference at 8:00 a.m. PT on Thursday, January 16, 2020
in San Francisco, CA.
A live webcast of the presentation and Q&A breakout session
will be accessible through the “Investors” section of the Company’s
website at www.angiodynamics.com and will be available for replay
following the event.
About AngioDynamics, Inc.
AngioDynamics, Inc. is a leading provider of innovative,
minimally invasive medical devices used by professional healthcare
providers for vascular access, peripheral vascular disease, and
oncology. AngioDynamics’ diverse product lines include
market-leading ablation systems, vascular access products,
angiographic products and accessories, drainage products,
thrombolytic products, and venous products. For more information,
visit www.angiodynamics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200106005218/en/
Investor Contact: AngioDynamics, Inc. Stephen Trowbridge, Sr.
Vice President, General Counsel & Interim CFO (518)
795-1408
AngioDynamics (NASDAQ:ANGO)
Historical Stock Chart
From Mar 2024 to Apr 2024
AngioDynamics (NASDAQ:ANGO)
Historical Stock Chart
From Apr 2023 to Apr 2024